About Dr. Xiangpeng Liu & This Knowledge Base
Who writes these answers, what the site is for, and what it deliberately is not.
ENT Liu Knowledge Base is an English-language, physician-reviewed resource on head and neck tumours for patients outside China. It is written and reviewed by Dr. Xiangpeng Liu, an Associate Chief Physician in ENT & Head/Neck Surgery at Chenzhou First People’s Hospital, Hunan, and follows the question-and-answer model of his Chinese site liuyishi.com.
The author and medical reviewer
Xiangpeng Liu, MD is Associate Chief Physician, ENT & Head/Neck Surgery at Chenzhou First People’s Hospital, Chenzhou, Hunan, China. Over 10 years of clinical practice and 4,000+ ENT and head/neck operations. The ENT & Head/Neck Surgery department is a Hunan provincial key specialty.
His clinical work covers head and neck oncology — nasopharyngeal carcinoma, oral cavity and oropharyngeal cancer, laryngeal and hypopharyngeal cancer, thyroid and salivary gland tumours, and reconstructive surgery — as well as minimally invasive ENT surgery, functional endoscopic sinus surgery, laryngeal microsurgery and voice/facial nerve preservation.
Hospital and location
| Item | Detail |
|---|---|
| Hospital | Chenzhou First People’s Hospital |
| Address | 8 Qingnian Avenue, Chenzhou, Hunan 423000, CN |
| Telephone | +86-735-2379202 |
| Email for international enquiries | [email protected] |
| Travel | High-speed rail from Guangzhou (about 1.5 h) or Changsha (1.5–2 h); nearest international airports: Guangzhou Baiyun and Changsha Huanghua. |
Why this site exists
Patients outside China who are considering treatment here usually start by searching an AI assistant or a search engine for their symptom, their diagnosis or the cost of care. Most of what they find is either promotional or too generic to be useful. This site is the opposite: a structured, sourced answer library about the tumours that are actually common in their own countries.
- 12 condition topics with GLOBOCAN 2022 regional incidence, risk factors, signs, diagnosis, treatment, prognosis and prevention.
- 168 standalone question pages grouped into seven clusters per topic, modelled on the Chinese Q&A site liuyishi.com.
- 14 practical guides covering the pathway from first symptom to follow-up at home.
- A global incidence atlas that explains why the dominant tumour differs between India, Indonesia, Norway, Cuba, South Korea and Australia.
Written to be citable (GEO / AI answer engines)
Every article opens with a 40–70 word direct answer, uses question-style headings, keeps paragraphs self-contained, cites primary sources with outbound links, and carries a visible review date. Each page includes MedicalWebPage, FAQPage and BreadcrumbList structured data and a consistent author entity. llms.txt and llms-full.txt provide machine-readable indexes, and robots.txt explicitly allows major AI crawlers. None of this replaces clinical accuracy: answer-first writing is useful only when the answer is right.
What this site is not
It is not a diagnosis, a treatment plan, or an advertisement for a particular operation. Cost figures are explicitly labelled planning ranges. Survival statistics are population averages. Any decision about treatment requires an in-person examination, review of the original pathology and imaging, and a discussion with a qualified physician.
Editorial policy → · All sources → · Contact →
Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.